vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Park Hotels & Resorts Inc. (PK). Click either name above to swap in a different company.
Park Hotels & Resorts Inc. is the larger business by last-quarter revenue ($630.0M vs $493.8M, roughly 1.3× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 1.9%, a 4.9% gap on every dollar of revenue. On growth, Park Hotels & Resorts Inc. posted the faster year-over-year revenue change (-1.3% vs -1.7%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -4.2%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Park Hotels & Resorts is an American real estate investment trust (REIT) focused on hotel properties, based in Tysons, Virginia. It was formed in 2017 as a spin-off from Hilton Worldwide.
MD vs PK — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $630.0M |
| Net Profit | $33.7M | $12.0M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | 9.8% |
| Net Margin | 6.8% | 1.9% |
| Revenue YoY | -1.7% | -1.3% |
| Net Profit YoY | 10.5% | 121.1% |
| EPS (diluted) | $0.40 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $630.0M | ||
| Q4 25 | $493.8M | $629.0M | ||
| Q3 25 | $492.9M | $610.0M | ||
| Q2 25 | $468.8M | $672.0M | ||
| Q1 25 | $458.4M | $630.0M | ||
| Q4 24 | $502.4M | $625.0M | ||
| Q3 24 | $511.2M | $649.0M | ||
| Q2 24 | $504.3M | $686.0M |
| Q1 26 | — | $12.0M | ||
| Q4 25 | $33.7M | $-205.0M | ||
| Q3 25 | $71.7M | $-16.0M | ||
| Q2 25 | $39.3M | $-5.0M | ||
| Q1 25 | $20.7M | $-57.0M | ||
| Q4 24 | $30.5M | $66.0M | ||
| Q3 24 | $19.4M | $54.0M | ||
| Q2 24 | $-153.0M | $64.0M |
| Q1 26 | — | 9.8% | ||
| Q4 25 | 9.9% | -26.1% | ||
| Q3 25 | 13.8% | 9.7% | ||
| Q2 25 | 12.8% | 9.7% | ||
| Q1 25 | 7.0% | 1.1% | ||
| Q4 24 | 7.8% | 13.3% | ||
| Q3 24 | 6.6% | 14.6% | ||
| Q2 24 | -31.3% | 17.6% |
| Q1 26 | — | 1.9% | ||
| Q4 25 | 6.8% | -32.6% | ||
| Q3 25 | 14.5% | -2.6% | ||
| Q2 25 | 8.4% | -0.7% | ||
| Q1 25 | 4.5% | -9.0% | ||
| Q4 24 | 6.1% | 10.6% | ||
| Q3 24 | 3.8% | 8.3% | ||
| Q2 24 | -30.3% | 9.3% |
| Q1 26 | — | $0.05 | ||
| Q4 25 | $0.40 | $-1.04 | ||
| Q3 25 | $0.84 | $-0.08 | ||
| Q2 25 | $0.46 | $-0.02 | ||
| Q1 25 | $0.24 | $-0.29 | ||
| Q4 24 | $0.37 | $0.32 | ||
| Q3 24 | $0.23 | $0.26 | ||
| Q2 24 | $-1.84 | $0.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $156.0M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $3.1B |
| Total Assets | $2.2B | — |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $156.0M | ||
| Q4 25 | $375.2M | $232.0M | ||
| Q3 25 | $340.1M | $278.0M | ||
| Q2 25 | $224.7M | $319.0M | ||
| Q1 25 | $99.0M | $233.0M | ||
| Q4 24 | $229.9M | $402.0M | ||
| Q3 24 | $103.8M | $480.0M | ||
| Q2 24 | $19.4M | $449.0M |
| Q1 26 | — | — | ||
| Q4 25 | $570.5M | $3.9B | ||
| Q3 25 | $577.2M | $3.9B | ||
| Q2 25 | $583.9M | $3.9B | ||
| Q1 25 | $590.5M | $3.9B | ||
| Q4 24 | $597.1M | $3.9B | ||
| Q3 24 | — | $3.9B | ||
| Q2 24 | — | $3.9B |
| Q1 26 | — | $3.1B | ||
| Q4 25 | $865.9M | $3.1B | ||
| Q3 25 | $890.7M | $3.4B | ||
| Q2 25 | $833.8M | $3.4B | ||
| Q1 25 | $789.2M | $3.5B | ||
| Q4 24 | $764.9M | $3.6B | ||
| Q3 24 | $732.5M | $3.8B | ||
| Q2 24 | $706.5M | $3.8B |
| Q1 26 | — | — | ||
| Q4 25 | $2.2B | $7.7B | ||
| Q3 25 | $2.2B | $8.8B | ||
| Q2 25 | $2.1B | $8.9B | ||
| Q1 25 | $2.0B | $8.9B | ||
| Q4 24 | $2.2B | $9.2B | ||
| Q3 24 | $2.1B | $9.2B | ||
| Q2 24 | $2.0B | $9.2B |
| Q1 26 | — | — | ||
| Q4 25 | 0.66× | 1.23× | ||
| Q3 25 | 0.65× | 1.14× | ||
| Q2 25 | 0.70× | 1.12× | ||
| Q1 25 | 0.75× | 1.11× | ||
| Q4 24 | 0.78× | 1.06× | ||
| Q3 24 | — | 1.03× | ||
| Q2 24 | — | 1.03× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 3.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $114.1M | $105.0M | ||
| Q3 25 | $137.3M | $99.0M | ||
| Q2 25 | $137.2M | $108.0M | ||
| Q1 25 | $-117.5M | $86.0M | ||
| Q4 24 | $133.0M | $80.0M | ||
| Q3 24 | $91.8M | $140.0M | ||
| Q2 24 | $107.0M | $117.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-3.0M | ||
| Q3 25 | — | $31.0M | ||
| Q2 25 | — | $65.0M | ||
| Q1 25 | — | $9.0M | ||
| Q4 24 | — | $17.0M | ||
| Q3 24 | — | $97.0M | ||
| Q2 24 | — | $66.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | -0.5% | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | — | 9.7% | ||
| Q1 25 | — | 1.4% | ||
| Q4 24 | — | 2.7% | ||
| Q3 24 | — | 14.9% | ||
| Q2 24 | — | 9.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | 17.2% | ||
| Q3 25 | — | 11.1% | ||
| Q2 25 | — | 6.4% | ||
| Q1 25 | — | 12.2% | ||
| Q4 24 | — | 10.1% | ||
| Q3 24 | — | 6.6% | ||
| Q2 24 | — | 7.4% |
| Q1 26 | — | — | ||
| Q4 25 | 3.39× | — | ||
| Q3 25 | 1.91× | — | ||
| Q2 25 | 3.49× | — | ||
| Q1 25 | -5.66× | — | ||
| Q4 24 | 4.36× | 1.21× | ||
| Q3 24 | 4.72× | 2.59× | ||
| Q2 24 | — | 1.83× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
PK
| Comparable Hotel Revenues | $617.0M | 98% |
| Other | $13.0M | 2% |
